Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

BD BACTEC FX40 Blood Culture Instrument Now Communicates with the BD EpiCenter Data Management System

Published: Saturday, June 14, 2014
Last Updated: Saturday, June 14, 2014
Bookmark and Share
Low-Volume Clinical Laboratories Now Have Access to Advanced Data Management with New Blood Culture Instrument Connectivity

BD Diagnostics, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company, has announced its launch of the BD BACTEC FX40 Blood Culture System with connectivity to the BD EpiCenter Microbiology Data Management System. This communication enables access to advanced reporting capabilities, connectivity to the hospital's Laboratory Information System (LIS) and access to the unique BD Blood Volume Monitoring Software.

Introduced in August 2013, the BD BACTEC FX40 Blood Culture System offers low-volume clinical laboratories the same state-of-the-art workflow and performance of the BD BACTEC FX blood culture system, with BD's exclusive vial-activated workflow. Communication with the BDEpiCenter Data Management System also provides access to the unique BD BACTEC Blood Volume Monitoring Software. This software offers automatic measurement and reporting of blood volume averages in BD BACTEC Plus Aerobic/F media bottles for patient populations. The ability to automatically track blood volumes gives laboratory professionals the confidence and ability to provide quality blood culture testing while improving their effectiveness in detecting bacteria, yeast and fungi in blood. A variety of reports can be generated to track, display and communicate average blood volumes collected from across the hospital or by a specific phlebotomist.

"We're pleased to be able to offer laboratories the convenience of a lower-volume blood culture instrument, with all of the advantages of full integration with the LIS," said Alberto Mas, President, BD Diagnostics Diagnostic Systems. "BD is committed to providing laboratory professionals with solutions that enable them to follow industry-recommended blood specimen collection best practices, including monitoring and providing feedback on collected blood volumes, and by providing a steady supply of product."

The volume of blood collected is the single most important factor affecting organism recovery in blood cultures.1 In fact, in adult blood culture specimens, recovery increases by approximately three percent for each additional milliliter of blood obtained.2 As a result, commonly accepted best practices, such as those outlined in the CLSI guidelines, call for 20 to 30 mL of blood collected per venipuncture or set, two to three sets per episode.3 Additionally, laboratory accreditation agencies, such as the College of American Pathologists, require that laboratories periodically monitor collected blood volumes and provide feedback to clinical staff.4

The BD BACTEC Blood Culture System is a fully automated microbiology growth and detection system designed to detect microbial growth from blood specimens. The BD BACTEC FX40 Instrument with connectivity to the BD EpiCenter Data Management System represents one of several new advancements in the blood culture arena for BD Diagnostics, a leader in blood culture solutions for more than 25 years. The BACTEC FX and the BD BACTEC 9000 families of continuous monitoring blood culturing instruments offer performance, safety, reliability, ease of use, media quality and service to meet the needs of today's top clinical laboratories.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases
Two-year trial did not produce expected metabolic changes, but influenced other life span markers.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Computerized Flexible Needles Prove Themselves in Biological Tissue
The advantage of the system is that you can avoid obstacles with the needles or critical tissues and that the system during the insertion of the needle in real time can adjust the path if, for example, the tissue deforms.
DARWIN 2 24-week Monotherapy Data in RA Confirm Previous Results
Safety profile in DARWIN 2 consistent with previous filgotinib RA studies.
Researchers Publish Landmark “Basket Study”
Researchers from Memorial Sloan Kettering Cancer Center (MSK) have announced results from the first published basket study, a new form of clinical trial design that explores responses to drugs based on the specific mutations in patients’ tumors rather than where their cancer originated.
Agricultural Intervention Improves HIV Outcomes
A multifaceted farming intervention can reduce food insecurity while improving HIV outcomes in patients in Kenya, according to a randomized, controlled trial led by researchers at UC San Francisco.
Overdose of Vitamin D in Teenagers May Lead to Increased Cholesterol Levels
Dosing obese teens with vitamin D shows no benefits for their heart health or diabetes risk, and could have the unintended consequences of increasing cholesterol and fat-storing triglycerides. These are the latest findings in a series of Mayo Clinic studies in childhood obesity.
Phase 2 Trials Underway for New Single Dose Malaria Treatment
The new drug, which prevents the malaria parasite from reproducing and spreading, is now undergoing Phase II clinical trials in humans.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!